Y-Biologics Competitors and Similar CompaniesClear all
Y-Biologics's competitors and similar companies include G1 Therapeutics, Immunomedics, Alpine Immune Sciences and DotBio.
 Y-Biologics Y-Biologics (와이바이오로직스) is a biopharmaceutical company engaged in the discovery and development of antibody therapeutics in fields of immuno-oncology. |  G1 Therapeutics G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer. |  Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer. |  Alpine Immune Sciences Alpine Immune Sciences is a biotechnology company that develops protein-based immunotherapies. | ||
Founding Date | Founding Date 2007 | Founding Date 2008 | Founding Date 1982 | Founding Date 2015 | Founding Date 2018 |
Type | Type Private | Type Public | Type Subsidiary | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations HQ | Locations Durham, US HQ | Locations Morris Plains, US HQ | Locations Seattle, US HQ | Locations Singapore, SG HQ |
Employees | Employees N/A | Employees 17015% increase | Employees 8914% decrease | Employees 484% decrease | Employees 195% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $82.5m (FY, 2023) | Revenue (est.) $295k (FY, 2019) | Revenue (est.) $58.9m (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $7.2m (FY, 2023) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $75.3m (FY, 2023) | Gross profit $295k (FY, 2019) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income ($48m) (FY, 2023) | Net income ($357.3m) (FY, 2019) | Net income ($32.2m) (FY, 2023) | Net income N/A |
Operating ⚠ | |||||
Patents (US) | Patents (US) N/A | Patents (US) 40 (FY, 2020) | Patents (US) 405 (Sep, 2022) | Patents (US) N/A | Patents (US) N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 289.6m | Total funding raised $ 30m | Total funding raised $ 49.3m | Total funding raised $ 2.5m |
For sources of this data, please see the company profile
View Company Profiles
G1 Therapeutics
HQ
Durham, US
Employees
170↑ 15% increase
G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.
View companyImmunomedics
HQ
Morris Plains, US
Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.
View companyAlpine Immune Sciences
HQ
Seattle, US
Alpine Immune Sciences is a biotechnology company that develops protein-based immunotherapies.
View company
DotBio
HQ
Singapore, SG
Employees
19↓ 5% decrease
DotBio is a biopharmaceutical company specializing in domain antibody therapies.
View company